GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (NYSE:ZTS) » Definitions » Cyclically Adjusted PB Ratio

Zoetis (Zoetis) Cyclically Adjusted PB Ratio : 24.94 (As of Jun. 04, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Zoetis Cyclically Adjusted PB Ratio?

As of today (2024-06-04), Zoetis's current share price is $171.06. Zoetis's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $6.86. Zoetis's Cyclically Adjusted PB Ratio for today is 24.94.

The historical rank and industry rank for Zoetis's Cyclically Adjusted PB Ratio or its related term are showing as below:

ZTS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 21.36   Med: 31.6   Max: 47
Current: 24.73

During the past years, Zoetis's highest Cyclically Adjusted PB Ratio was 47.00. The lowest was 21.36. And the median was 31.60.

ZTS's Cyclically Adjusted PB Ratio is ranked worse than
98.07% of 724 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs ZTS: 24.73

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zoetis's adjusted book value per share data for the three months ended in Mar. 2024 was $11.069. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.86 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zoetis Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Zoetis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Cyclically Adjusted PB Ratio Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 36.18 46.55 26.56 30.21

Zoetis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.66 28.37 27.43 30.21 24.68

Competitive Comparison of Zoetis's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zoetis's Cyclically Adjusted PB Ratio falls into.



Zoetis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zoetis's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=171.06/6.86
=24.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Zoetis's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.069/131.7762*131.7762
=11.069

Current CPI (Mar. 2024) = 131.7762.

Zoetis Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.515 100.560 3.296
201409 2.721 100.428 3.570
201412 2.615 99.070 3.478
201503 2.554 99.621 3.378
201506 2.355 100.684 3.082
201509 2.466 100.392 3.237
201512 2.147 99.792 2.835
201603 2.347 100.470 3.078
201606 2.739 101.688 3.549
201609 3.207 101.861 4.149
201612 3.017 101.863 3.903
201703 3.275 102.862 4.196
201706 3.502 103.349 4.465
201709 4.077 104.136 5.159
201712 3.641 104.011 4.613
201803 4.044 105.290 5.061
201806 4.085 106.317 5.063
201809 4.404 106.507 5.449
201812 4.556 105.998 5.664
201903 4.837 107.251 5.943
201906 5.046 108.070 6.153
201909 5.617 108.329 6.833
201912 5.695 108.420 6.922
202003 5.797 108.902 7.015
202006 6.278 108.767 7.606
202009 7.579 109.815 9.095
202012 7.929 109.897 9.508
202103 8.609 111.754 10.151
202106 9.173 114.631 10.545
202109 9.884 115.734 11.254
202112 9.613 117.630 10.769
202203 9.885 121.301 10.739
202206 9.774 125.017 10.302
202209 9.997 125.227 10.520
202212 9.497 125.222 9.994
202303 9.717 127.348 10.055
202306 10.038 128.729 10.276
202309 11.051 129.860 11.214
202312 10.902 129.419 11.101
202403 11.069 131.776 11.069

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zoetis  (NYSE:ZTS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zoetis Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Zoetis's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis (Zoetis) Business Description

Industry
Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Executives
Roxanne Lagano officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Kristin C Peck officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Heidi C. Chen officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Robert J Polzer officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Soria Ester Banque officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Rimma Driscoll officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Jamie Brannan officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Vanessa Broadhurst director ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Willie M Reed director C/O ZOETIS, 100 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Nicholas Ashton officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Roman Trawicki officer: Executive Vice President C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Glenn David officer: SVP and Acting CFO C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Astorga Jeannette Ferran officer: Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Catherine A. Knupp officer: Executive Vice President C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07940
Gregory Norden director 16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005

Zoetis (Zoetis) Headlines

From GuruFocus

Q1 2023 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2021 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2021 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Zoetis Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Zoetis Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Zoetis Inc at Jefferies Pet Summit (Virtual) Transcript

By GuruFocus Research 01-23-2024